Imatinib Tablets

Imatinib Tablets

2050 INR/Piece

Product Details:

  • Enzyme Types Other
  • Feature Food Grade
  • Ingredients Other
  • Fermentation Smell Normal Smell
  • Storage Instructions Room temperature
  • Shelf Life 2 Years
  • Click to view more
X

Imatinib Tablets Price And Quantity

  • 2050 INR/Piece
  • 10.00 - 100.00 INR/Piece
  • 5000-10000 Piece

Imatinib Tablets Product Specifications

  • Other
  • Normal Smell
  • Food Grade
  • Room temperature
  • 2 Years
  • Other

Imatinib Tablets Trade Information

  • Cash Against Delivery (CAD) Cash in Advance (CID) Cash Advance (CA)
  • 10000 Piece Per Week
  • 7-15 Days
  • Yes
  • Sample costs shipping and taxes has to be paid by the buyer
  • corrugated box
  • South America Western Europe Eastern Europe Middle East North America Australia Central America Asia Africa
  • All India

Product Description

Imatinib Tablets, which include Imatinib as the active ingredient, are used to treat a variety of cancers, including gastrointestinal stromal tumours (GISTs) and chronic myeloid leukaemia (CML). Tyrosine kinase inhibitor imatinib inhibits the development and division of cancer cells by preventing the activity of particular proteins. The oral tablets are normally prescribed by a medical professional with oncology experience. Nausea, diarrhoea, and cramping of the muscles are examples of typical adverse effects. Imatinib tablets have been effective in treating a number of malignancies, perhaps benefiting patients and leading to better results. Individual responses to the medicine, however, may differ, necessitating constant medical supervision throughout the course of treatment.

 

Imatinib Tablet Features:

1. Imatinib, a tyrosine kinase inhibitor with a reputation for being beneficial in the treatment of specific cancers, is the active ingredient in the pills.

2. Cancer Treatment: Gastrointestinal stromal tumours (GISTs) and chronic myeloid leukaemia (CML) are the two cancers for which imatinib tablets are expressly prescribed.

3. The tablets are administered orally, offering a practical and non-intrusive means of drug delivery.

4. Tyrosine Kinase Inhibition: Imatinib blocks particular proteins involved in the growth and division of cancer cells, slowing the growth of tumours.

5. Treatment Plan: The medicine is prescribed and dosed according to each patient's unique medical situation, offering a treatment plan that is particular to them.


Imatinib Tablet Benefits:

1. Effective Cancer Management: Imatinib Tablets have shown success in managing gastrointestinal stromal tumours and chronic myeloid leukaemia, potentially providing benefits and better results for individuals with these particular cancers.

2. Imatinib is a targeted medication that targets cancer cells only, causing less harm to healthy cells and fewer side effects than conventional chemotherapy.

3. Improved Disease management: Imatinib helps manage tumour progression and may cause tumour shrinking by blocking the proliferation of cancer cells, giving patients symptom relief and improving disease management.

4. Long-Term Remission: Imatinib treatment may occasionally result in long-term remission or stable illness, giving patients the possibility to live cancer-free for longer or better control their condition.

5. Combination Therapy: Imatinib Tablets can be used in a multi-drug regimen or in conjunction with other therapies to improve overall survival and treatment outcomes.

6. Alternative Treatment Option: Imatinib can be used as an alternative to or in conjunction with existing treatments for some cancer types, giving patients more therapeutic options.

7. Professional Administration: Imatinib Tablets can be easily self-administered through oral administration, which eliminates the need for frequent hospital visits.


Individual responses to imatinib tablets can differ, so it's vital to remember that continuous medical supervision and monitoring are necessary to manage any potential side effects and improve treatment outcomes. Throughout the course of treatment, patients should speak with their medical specialists for personalised counsel and direction.

 

Product Details :


Dose

As Prescribed

Form

Tablet

Generic Name

Imatinib

Manufacturer

Cipla Ltd

Packaging Size

1 x 10

Product Type

Finished Product

Syrength

400 Mg

Usage

Hospital,Clinical

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Anti Cancer Medicines & Injections' category



"We mainly deliver our products to the foreign countries."
Back to top